A trial looking at volrustomig and chemotherapy for mesothelioma of the lungs (eVOLVE-Meso)

This trial is comparing volrustomig and chemotherapy with standard treatment for mesothelioma of the lungs.

Volrustomig is pronounced vol-rus-to-mig. It is also called MEDI5752.

This trial is for people:

• having their first treatment for mesothelioma of the lungs and

• whose mesothelioma has spread elsewhere in the body and it isn’t possible to remove it with surgery